Benzinga Florida Interviews: Dr. Constantin von der Groeben: Co-founder & Managing Director: DEMECAN
About the Author: HCN News Team
The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Related Posts
Latest News
Single DMT Dose Shows Promise in Cutting TRD Symptoms
NEW YORK – A single intravenous dose of the psychedelic compound dimethyltryptamine (DMT), combined with psychological support, produced rapid and sustained reductions in depressive symptoms among adults with moderate-to-severe major depressive disorder, according to results ...
Massachusetts Tops $9 Billion in Cannabis Sales, Eyes Cultivation License Freeze
BOSTON – Massachusetts adult-use Cannabis retailers have surpassed $9 billion in gross sales since the market launched in late 2018, according to the state's Cannabis Control Commission. The milestone was reached on February 4, driven ...
What is Cannabis 3.0? From Brand Expansion to Platform Discipline
LOS ANGELES- If Cannabis 1.0 was legalization and survival, and Cannabis 2.0 was scale and brand proliferation, Cannabis 3.0 is something far more structural. It is the shift from product velocity to process discipline. From ...
